Pasireotide Extended-Release Injection and Peg Intron RP
Determining the interaction of Pasireotide Extended-Release Injection and Peg Intron RP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: PegIntron, Pegintron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-PEG-3350 with Electolytes
- Pasireotide Extended-Release Injection-PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride
- Pasireotide Extended-Release Injection-PEG-Prep and Bisacodyl
- Pasireotide Extended-Release Injection-PEG3350
- Pasireotide Extended-Release Injection-Pegademase bovine
- Pasireotide Extended-Release Injection-Pegademase Bovine Injection
- Peg Intron RP-Pasireotide Injection
- Peg Intron RP-Pasireotide Subcutaneous
- Peg Intron RP-Patanase
- Peg Intron RP-Patiromer
- Peg Intron RP-Patiromer Sorbitex Calcium
- Peg Intron RP-Pavacot